Umb Bank, N.A. Amphastar Pharmaceuticals, Inc. Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
A detailed history of Umb Bank, N.A. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 53 shares of AMPH stock, worth $1,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53
Previous 103
48.54%
Holding current value
$1,707
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.8MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$87.4 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$62.7 Million0.22% of portfolio
-
Td Asset Management Inc1.84MShares$59.3 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$52 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.58B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...